Design and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas.
Authors
Lamarca, AngelaWalter, T
Pavel, M
Borbath, I
Freis, P
Nuñez, B
Childs, A
McNamara, Mairéad G
Hubner, Richard A
Garcia-Carbonero, R
Meyer, T
Valle, Juan W
Barriuso, Jorge
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust (ENETS Centre of Excellence), Manchester, UKIssue Date
2017-01
Metadata
Show full item recordAbstract
Prognostic markers for risk stratification of patients with gastrointestinal high-grade neuroendocrine carcinomas (GI-NECs) are lacking; we designed and validated a prognostic score for overall survival (OS).Citation
Design and validation of the GI-NEC score to prognosticate overall survival in patients with high-grade gastrointestinal neuroendocrine carcinomas. 2017, 109(5): J Natl Cancer InstJournal
Journal of the National Cancer InstituteDOI
10.1093/jnci/djw277PubMed ID
28130474Type
ArticleLanguage
enISSN
1460-2105ae974a485f413a2113503eed53cd6c53
10.1093/jnci/djw277
Scopus Count
Collections
Related articles
- High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
- Authors: Alese OB, Jiang R, Shaib W, Wu C, Akce M, Behera M, El-Rayes BF
- Issue date: 2019 Jul
- Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia.
- Authors: Abdelmalak R, Lythgoe MP, Evans J, Flynn M, Waters J, Webb A, Pinato DJ, Sharma R
- Issue date: 2021 Aug 23
- Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
- Authors: Galleberg RB, Knigge U, Tiensuu Janson E, Vestermark LW, Haugvik SP, Ladekarl M, Langer SW, Grønbæk H, Österlund P, Hjortland GO, Assmus J, Tang L, Perren A, Sorbye H
- Issue date: 2017 Sep
- A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
- Authors: Ulas A, Turkoz FP, Silay K, Tokluoglu S, Avci N, Oksuzoglu B, Alkis N
- Issue date: 2014
- Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
- Authors: Bigot F, Castanon E, Baldini C, Hollebecque A, Carmona A, Postel-Vinay S, Angevin E, Armand JP, Ribrag V, Aspeslagh S, Varga A, Bahleda R, Menis J, Gazzah A, Michot JM, Marabelle A, Soria JC, Massard C
- Issue date: 2017 Oct